Cargando…

Marked improvement in HbA(1c) following commencement of flash glucose monitoring in people with type 1 diabetes

AIMS/HYPOTHESIS: Minimal evidence supports the efficacy of flash monitoring in lowering HbA(1c). We sought to assess the impact of introducing flash monitoring in our centre. METHODS: We undertook a prospective observational study to assess change in HbA(1c) in 900 individuals with type 1 diabetes f...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyndall, Victoria, Stimson, Roland H., Zammitt, Nicola N., Ritchie, Stuart A., McKnight, John A., Dover, Anna R., Gibb, Fraser W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647076/
https://www.ncbi.nlm.nih.gov/pubmed/31177314
http://dx.doi.org/10.1007/s00125-019-4894-1
_version_ 1783437649754718208
author Tyndall, Victoria
Stimson, Roland H.
Zammitt, Nicola N.
Ritchie, Stuart A.
McKnight, John A.
Dover, Anna R.
Gibb, Fraser W.
author_facet Tyndall, Victoria
Stimson, Roland H.
Zammitt, Nicola N.
Ritchie, Stuart A.
McKnight, John A.
Dover, Anna R.
Gibb, Fraser W.
author_sort Tyndall, Victoria
collection PubMed
description AIMS/HYPOTHESIS: Minimal evidence supports the efficacy of flash monitoring in lowering HbA(1c). We sought to assess the impact of introducing flash monitoring in our centre. METHODS: We undertook a prospective observational study to assess change in HbA(1c) in 900 individuals with type 1 diabetes following flash monitoring (comparator group of 518 with no flash monitoring). Secondary outcomes included changes in hypoglycaemia, quality of life, flash monitoring data and hospital admissions. RESULTS: Those with baseline HbA(1c) ≥58 mmol/mol (7.5%) achieved a median −7 mmol/mol (interquartile range [IQR] −13 to −1) (0.6% [−1.2 to −0.1]%) change in HbA(1c) (p < 0.001). The percentage achieving HbA(1c) <58 mmol/mol rose from 34.2% to 50.9% (p < 0.001). Median follow-up was 245 days (IQR 182 to 330). Individuals not using flash monitoring experienced no change in HbA(1c) across a similar timescale (p = 0.508). Higher HbA(1c) (p < 0.001), younger age at diagnosis (p = 0.003) and lower social deprivation (p = 0.024) were independently associated with an HbA(1c) fall of ≥5 mmol/mol (0.5%). More symptomatic (OR 1.9, p < 0.001) and asymptomatic (OR 1.4, p < 0.001) hypoglycaemia was reported after flash monitoring. Following flash monitoring, regimen-related and emotional components of the diabetes distress scale improved although the proportion with elevated anxiety (OR 1.2, p = 0.028) and depression (OR 2.0, p < 0.001) scores increased. Blood glucose test strip use fell from 3.8 to 0.6 per day (p < 0.001). Diabetic ketoacidosis admissions fell significantly following flash monitoring (p = 0.043). CONCLUSIONS/INTERPRETATION: Flash monitoring is associated with significant improvements in HbA(1c) and fewer diabetic ketoacidosis admissions. Higher rates of hypoglycaemia may relate to greater recognition of hitherto unrecognised events. Impact upon quality of life parameters was mixed but overall treatment satisfaction was overwhelmingly positive. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-4894-1) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-6647076
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-66470762019-08-06 Marked improvement in HbA(1c) following commencement of flash glucose monitoring in people with type 1 diabetes Tyndall, Victoria Stimson, Roland H. Zammitt, Nicola N. Ritchie, Stuart A. McKnight, John A. Dover, Anna R. Gibb, Fraser W. Diabetologia Article AIMS/HYPOTHESIS: Minimal evidence supports the efficacy of flash monitoring in lowering HbA(1c). We sought to assess the impact of introducing flash monitoring in our centre. METHODS: We undertook a prospective observational study to assess change in HbA(1c) in 900 individuals with type 1 diabetes following flash monitoring (comparator group of 518 with no flash monitoring). Secondary outcomes included changes in hypoglycaemia, quality of life, flash monitoring data and hospital admissions. RESULTS: Those with baseline HbA(1c) ≥58 mmol/mol (7.5%) achieved a median −7 mmol/mol (interquartile range [IQR] −13 to −1) (0.6% [−1.2 to −0.1]%) change in HbA(1c) (p < 0.001). The percentage achieving HbA(1c) <58 mmol/mol rose from 34.2% to 50.9% (p < 0.001). Median follow-up was 245 days (IQR 182 to 330). Individuals not using flash monitoring experienced no change in HbA(1c) across a similar timescale (p = 0.508). Higher HbA(1c) (p < 0.001), younger age at diagnosis (p = 0.003) and lower social deprivation (p = 0.024) were independently associated with an HbA(1c) fall of ≥5 mmol/mol (0.5%). More symptomatic (OR 1.9, p < 0.001) and asymptomatic (OR 1.4, p < 0.001) hypoglycaemia was reported after flash monitoring. Following flash monitoring, regimen-related and emotional components of the diabetes distress scale improved although the proportion with elevated anxiety (OR 1.2, p = 0.028) and depression (OR 2.0, p < 0.001) scores increased. Blood glucose test strip use fell from 3.8 to 0.6 per day (p < 0.001). Diabetic ketoacidosis admissions fell significantly following flash monitoring (p = 0.043). CONCLUSIONS/INTERPRETATION: Flash monitoring is associated with significant improvements in HbA(1c) and fewer diabetic ketoacidosis admissions. Higher rates of hypoglycaemia may relate to greater recognition of hitherto unrecognised events. Impact upon quality of life parameters was mixed but overall treatment satisfaction was overwhelmingly positive. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-4894-1) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2019-06-09 2019 /pmc/articles/PMC6647076/ /pubmed/31177314 http://dx.doi.org/10.1007/s00125-019-4894-1 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Tyndall, Victoria
Stimson, Roland H.
Zammitt, Nicola N.
Ritchie, Stuart A.
McKnight, John A.
Dover, Anna R.
Gibb, Fraser W.
Marked improvement in HbA(1c) following commencement of flash glucose monitoring in people with type 1 diabetes
title Marked improvement in HbA(1c) following commencement of flash glucose monitoring in people with type 1 diabetes
title_full Marked improvement in HbA(1c) following commencement of flash glucose monitoring in people with type 1 diabetes
title_fullStr Marked improvement in HbA(1c) following commencement of flash glucose monitoring in people with type 1 diabetes
title_full_unstemmed Marked improvement in HbA(1c) following commencement of flash glucose monitoring in people with type 1 diabetes
title_short Marked improvement in HbA(1c) following commencement of flash glucose monitoring in people with type 1 diabetes
title_sort marked improvement in hba(1c) following commencement of flash glucose monitoring in people with type 1 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647076/
https://www.ncbi.nlm.nih.gov/pubmed/31177314
http://dx.doi.org/10.1007/s00125-019-4894-1
work_keys_str_mv AT tyndallvictoria markedimprovementinhba1cfollowingcommencementofflashglucosemonitoringinpeoplewithtype1diabetes
AT stimsonrolandh markedimprovementinhba1cfollowingcommencementofflashglucosemonitoringinpeoplewithtype1diabetes
AT zammittnicolan markedimprovementinhba1cfollowingcommencementofflashglucosemonitoringinpeoplewithtype1diabetes
AT ritchiestuarta markedimprovementinhba1cfollowingcommencementofflashglucosemonitoringinpeoplewithtype1diabetes
AT mcknightjohna markedimprovementinhba1cfollowingcommencementofflashglucosemonitoringinpeoplewithtype1diabetes
AT doverannar markedimprovementinhba1cfollowingcommencementofflashglucosemonitoringinpeoplewithtype1diabetes
AT gibbfraserw markedimprovementinhba1cfollowingcommencementofflashglucosemonitoringinpeoplewithtype1diabetes